Sale of BASF Textile Chemicals to Archroma Completed

Along with the official launch of the new Ineos-Solvay PVC joint venture Inovyn and BASF’s sale of its 25% stake in SolVin, another PVC jv, to Solvay, BASF has completed the sale of its textile chemicals business to Archroma.

The BASF business strategically complements its own portfolio and geographical presence and further solidifies its position as a clear industry leader in supplying chemicals and dyes to the global textile industry, said Archroma.

In 2014, the carve-out from Swiss specialty chemicals producer Clariant, currently owned by private equity investor SK Capital Partners acquired a stake in textile dyes and chemicals manufacturer M. Dohmen.

With the latest deal, the Swiss company said it will be able to build on BASF’s strong market positions in Asia and several other high-growth markets.

“The operational and intellectual synergies between BASF and Archroma will allow us to offer our customers the full breadth and depth of innovation, quality, reliability, expertise and market coverage they need,” said CEO Alexander Wessels.

Around 225 BASF employees, including 175 based in Asia, will transfer to the business. The combined textiles businesses will remain headquartered in Singapore.

The transfer of Karachi-based BASF Pakistan to Archroma is expected to take place in August of this year.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.